/ Not yet recruitingNot Applicable A 6 month open-label, flexible-dosage study to assess the safety and effectiveness of PROVIGIL® (Modafinil) treatment in children and adolescents with excessive sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea.
100 Clinical Results associated with Cephalon Europe Ltd.
0 Patents (Medical) associated with Cephalon Europe Ltd.
100 Deals associated with Cephalon Europe Ltd.
100 Translational Medicine associated with Cephalon Europe Ltd.